Molecular Mechanisms and Efficacy of Tislelizumab, a PD ‐1 Inhibitor Developed in China, in Non‐Small Cell Lung Cancer

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Yihao Liu, Wenjun Meng, Lu Pan, Haoling Zhang, Qinqin He
Format:	Artículo Open Access
Published:	Wiley 2026
Subjects:	Chemical Biology & Drug Design
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Internet